Selected research
Market Structure
Global Gene Expression Screening Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Gene Expression Screening Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Gene Expression Screening Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Gene Expression Screening Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Gene Expression Screening Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Gene Expression Screening Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Gene Expression Screening Service include EKF Diagnostics, Perkin Elmer, IntegraGen, Quest Diagnostics, Abbott Laboratories, Roche Diagnostics, Biocartis, Elitech Group and Interpace Diagnostics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Gene Expression Screening Service market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Gene Expression Screening Service and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Gene Expression Screening Service revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Gene Expression Screening Service market size, projected growth trends, production technologies, key applications, and end-use industries.
Gene Expression Screening Service Segment by Company
EKF Diagnostics
Perkin Elmer
IntegraGen
Quest Diagnostics
Abbott Laboratories
Roche Diagnostics
Biocartis
Elitech Group
Interpace Diagnostics
Qiagen
AutoGenomics
Bio-Rad Laboratories
Cepheid
Gene Expression Screening Service Segment by Type
High-Throughput Screening
Low-Throughput Screening
Gene Expression Screening Service Segment by Application
Pharmaceutical Industry
Agricultural Industry
Environmental Science
Others
Gene Expression Screening Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gene Expression Screening Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Gene Expression Screening Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gene Expression Screening Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Gene Expression Screening Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Gene Expression Screening Service industry.
Chapter 3: Detailed analysis of Gene Expression Screening Service companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gene Expression Screening Servicerevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- High-Throughput Screening
- Low-Throughput Screening
Applications
- Pharmaceutical Industry
- Agricultural Industry
- Environmental Science
- Others
Companies covered
- EKF Diagnostics
- Perkin Elmer
- IntegraGen
- Quest Diagnostics
- Abbott Laboratories
- Roche Diagnostics
- Biocartis
- Elitech Group
- Interpace Diagnostics
- Qiagen
- AutoGenomics
- Bio-Rad Laboratories
- Cepheid
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Gene Expression Screening Service Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 High-Throughput Screening
- 1.2.3 Low-Throughput Screening
- 1.3 Market Analysis by Application
- 1.3.1 Global Gene Expression Screening Service Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Pharmaceutical Industry
- 1.3.3 Agricultural Industry
- 1.3.4 Environmental Science
- 1.3.5 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Gene Expression Screening Service Growth Trends by Region
- 1.5.1 Global Gene Expression Screening Service Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Gene Expression Screening Service Market Size by Region (2021-2026)
- 1.5.3 Gene Expression Screening Service Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Gene Expression Screening Service Market Dynamics
- 2.1 Gene Expression Screening Service Industry Trends
- 2.2 Gene Expression Screening Service Industry Drivers
- 2.3 Gene Expression Screening Service Industry Opportunities and Challenges
- 2.4 Gene Expression Screening Service Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Gene Expression Screening Service Revenue by Company (2021-2026)
- 3.2 Global Gene Expression Screening Service Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Gene Expression Screening Service Key Company Head office and Area Served
- 3.4 Global Gene Expression Screening Service Company, Product Type & Application
- 3.5 Global Gene Expression Screening Service Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Gene Expression Screening Service Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Gene Expression Screening Service Players Market Share by Revenue in 2025
- 3.6.3 2025 Gene Expression Screening Service Tier 1, Tier 2, and Tier 3
4 Gene Expression Screening Service Market by Type
- 4.1 Global Gene Expression Screening Service Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Gene Expression Screening Service Market Size by Type (2021-2032)
- 4.3 Global Gene Expression Screening Service Market Size Share by Type (2021-2032)
5 Gene Expression Screening Service Market by Application
- 5.1 Global Gene Expression Screening Service Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Gene Expression Screening Service Market Size by Application (2021-2032)
- 5.3 Global Gene Expression Screening Service Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 EKF Diagnostics
- 6.1.1 EKF Diagnostics Company Information
- 6.1.2 EKF Diagnostics Business Overview
- 6.1.3 EKF Diagnostics Gene Expression Screening Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 EKF Diagnostics Gene Expression Screening Service Product Portfolio
- 6.1.5 EKF Diagnostics Recent Developments
- 6.2 Perkin Elmer
- 6.2.1 Perkin Elmer Company Information
- 6.2.2 Perkin Elmer Business Overview
- 6.2.3 Perkin Elmer Gene Expression Screening Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Perkin Elmer Gene Expression Screening Service Product Portfolio
- 6.2.5 Perkin Elmer Recent Developments
- 6.3 IntegraGen
- 6.3.1 IntegraGen Company Information
- 6.3.2 IntegraGen Business Overview
- 6.3.3 IntegraGen Gene Expression Screening Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 IntegraGen Gene Expression Screening Service Product Portfolio
- 6.3.5 IntegraGen Recent Developments
- 6.4 Quest Diagnostics
- 6.4.1 Quest Diagnostics Company Information
- 6.4.2 Quest Diagnostics Business Overview
- 6.4.3 Quest Diagnostics Gene Expression Screening Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Quest Diagnostics Gene Expression Screening Service Product Portfolio
- 6.4.5 Quest Diagnostics Recent Developments
- 6.5 Abbott Laboratories
- 6.5.1 Abbott Laboratories Company Information
- 6.5.2 Abbott Laboratories Business Overview
- 6.5.3 Abbott Laboratories Gene Expression Screening Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Abbott Laboratories Gene Expression Screening Service Product Portfolio
- 6.5.5 Abbott Laboratories Recent Developments
- 6.6 Roche Diagnostics
- 6.6.1 Roche Diagnostics Company Information
- 6.6.2 Roche Diagnostics Business Overview
- 6.6.3 Roche Diagnostics Gene Expression Screening Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Roche Diagnostics Gene Expression Screening Service Product Portfolio
- 6.6.5 Roche Diagnostics Recent Developments
- 6.7 Biocartis
- 6.7.1 Biocartis Company Information
- 6.7.2 Biocartis Business Overview
- 6.7.3 Biocartis Gene Expression Screening Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Biocartis Gene Expression Screening Service Product Portfolio
- 6.7.5 Biocartis Recent Developments
- 6.8 Elitech Group
- 6.8.1 Elitech Group Company Information
- 6.8.2 Elitech Group Business Overview
- 6.8.3 Elitech Group Gene Expression Screening Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Elitech Group Gene Expression Screening Service Product Portfolio
- 6.8.5 Elitech Group Recent Developments
- 6.9 Interpace Diagnostics
- 6.9.1 Interpace Diagnostics Company Information
- 6.9.2 Interpace Diagnostics Business Overview
- 6.9.3 Interpace Diagnostics Gene Expression Screening Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Interpace Diagnostics Gene Expression Screening Service Product Portfolio
- 6.9.5 Interpace Diagnostics Recent Developments
- 6.10 Qiagen
- 6.10.1 Qiagen Company Information
- 6.10.2 Qiagen Business Overview
- 6.10.3 Qiagen Gene Expression Screening Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Qiagen Gene Expression Screening Service Product Portfolio
- 6.10.5 Qiagen Recent Developments
- 6.11 AutoGenomics
- 6.11.1 AutoGenomics Company Information
- 6.11.2 AutoGenomics Business Overview
- 6.11.3 AutoGenomics Gene Expression Screening Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 AutoGenomics Gene Expression Screening Service Product Portfolio
- 6.11.5 AutoGenomics Recent Developments
- 6.12 Bio-Rad Laboratories
- 6.12.1 Bio-Rad Laboratories Company Information
- 6.12.2 Bio-Rad Laboratories Business Overview
- 6.12.3 Bio-Rad Laboratories Gene Expression Screening Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Bio-Rad Laboratories Gene Expression Screening Service Product Portfolio
- 6.12.5 Bio-Rad Laboratories Recent Developments
- 6.13 Cepheid
- 6.13.1 Cepheid Company Information
- 6.13.2 Cepheid Business Overview
- 6.13.3 Cepheid Gene Expression Screening Service Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Cepheid Gene Expression Screening Service Product Portfolio
- 6.13.5 Cepheid Recent Developments
7 North America
- 7.1 North America Gene Expression Screening Service Market Size (2021-2032)
- 7.2 North America Gene Expression Screening Service Market Size by Type
- 7.2.1 North America Gene Expression Screening Service Market Size by Type (2021-2026)
- 7.2.2 North America Gene Expression Screening Service Market Size by Type (2027-2032)
- 7.2.3 North America Gene Expression Screening Service Market Share by Type (2021-2032)
- 7.3 North America Gene Expression Screening Service Market Size by Application
- 7.3.1 North America Gene Expression Screening Service Market Size by Application (2021-2026)
- 7.3.2 North America Gene Expression Screening Service Market Size by Application (2027-2032)
- 7.3.3 North America Gene Expression Screening Service Market Share by Application (2021-2032)
- 7.4 North America Gene Expression Screening Service Market Size by Country
- 7.4.1 North America Gene Expression Screening Service Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Gene Expression Screening Service Market Size by Country (2021-2026)
- 7.4.3 North America Gene Expression Screening Service Market Size by Country (2027-2032)
- 7.4.4 North America Gene Expression Screening Service Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Gene Expression Screening Service Market Size (2021-2032)
- 8.2 Europe Gene Expression Screening Service Market Size by Type
- 8.2.1 Europe Gene Expression Screening Service Market Size by Type (2021-2026)
- 8.2.2 Europe Gene Expression Screening Service Market Size by Type (2027-2032)
- 8.2.3 Europe Gene Expression Screening Service Market Share by Type (2021-2032)
- 8.3 Europe Gene Expression Screening Service Market Size by Application
- 8.3.1 Europe Gene Expression Screening Service Market Size by Application (2021-2026)
- 8.3.2 Europe Gene Expression Screening Service Market Size by Application (2027-2032)
- 8.3.3 Europe Gene Expression Screening Service Market Share by Application (2021-2032)
- 8.4 Europe Gene Expression Screening Service Market Size by Country
- 8.4.1 Europe Gene Expression Screening Service Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Gene Expression Screening Service Market Size by Country (2021-2026)
- 8.4.3 Europe Gene Expression Screening Service Market Size by Country (2027-2032)
- 8.4.4 Europe Gene Expression Screening Service Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Gene Expression Screening Service Market Size (2021-2032)
- 9.2 China Gene Expression Screening Service Market Size by Type
- 9.2.1 China Gene Expression Screening Service Market Size by Type (2021-2026)
- 9.2.2 China Gene Expression Screening Service Market Size by Type (2027-2032)
- 9.2.3 China Gene Expression Screening Service Market Share by Type (2021-2032)
- 9.3 China Gene Expression Screening Service Market Size by Application
- 9.3.1 China Gene Expression Screening Service Market Size by Application (2021-2026)
- 9.3.2 China Gene Expression Screening Service Market Size by Application (2027-2032)
- 9.3.3 China Gene Expression Screening Service Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Gene Expression Screening Service Market Size (2021-2032)
- 10.2 Asia Gene Expression Screening Service Market Size by Type
- 10.2.1 Asia Gene Expression Screening Service Market Size by Type (2021-2026)
- 10.2.2 Asia Gene Expression Screening Service Market Size by Type (2027-2032)
- 10.2.3 Asia Gene Expression Screening Service Market Share by Type (2021-2032)
- 10.3 Asia Gene Expression Screening Service Market Size by Application
- 10.3.1 Asia Gene Expression Screening Service Market Size by Application (2021-2026)
- 10.3.2 Asia Gene Expression Screening Service Market Size by Application (2027-2032)
- 10.3.3 Asia Gene Expression Screening Service Market Share by Application (2021-2032)
- 10.4 Asia Gene Expression Screening Service Market Size by Country
- 10.4.1 Asia Gene Expression Screening Service Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Gene Expression Screening Service Market Size by Country (2021-2026)
- 10.4.3 Asia Gene Expression Screening Service Market Size by Country (2027-2032)
- 10.4.4 Asia Gene Expression Screening Service Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Gene Expression Screening Service Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Gene Expression Screening Service Market Size by Type
- 11.2.1 South America, Middle East & Africa Gene Expression Screening Service Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Gene Expression Screening Service Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Gene Expression Screening Service Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Gene Expression Screening Service Market Size by Application
- 11.3.1 South America, Middle East & Africa Gene Expression Screening Service Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Gene Expression Screening Service Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Gene Expression Screening Service Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Gene Expression Screening Service Market Size by Country
- 11.4.1 South America, Middle East & Africa Gene Expression Screening Service Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Gene Expression Screening Service Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Gene Expression Screening Service Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Gene Expression Screening Service Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst